Abaloparatide increases BMD, improves bone turnover markers in men with osteoporosis
6 days ago - By Healio
SAN DIEGO - Men with osteoporosis receiving daily injections of abaloparatide had greater increases in bone mineral density at the lumbar spine, total hip and femoral neck at 12 months compared with placebo, according to a speaker.
As Healio previously reported, abaloparatide was approved by the FDA in April 2017 for the treatment of postmenopausal women with osteoporosis and a high risk for fractures. In new findings from a phase 3 study presented at the AACE Annual Scientific and Clinical Conference, abaloparatide was associated with improvements in BMD and in
Read more ...
The headlines of Master Doctor
Plant-based diet may lower prostate cancer risk, lead to favorable outcomes
A systematic review of 31 studies showed favorable results supporting the incorporation of a plant-based diet for men at risk for or diagnosed with prostate cancer. The...
Alzheimer's, Cognitive Impairment Linked With Choroid Plexus Volume
Increased volume of the choroid plexus, which produces and secretes cerebrospinal fluid , was tied to cognitive impairment and Alzheimer's disease, a retrospective study...